When PD-L1 expressed on cancer cells binds to PD-1 on CTLs, it limits the anti-cancer activity of the CTLs, and cancer cells can upregulate PD-L1 expression to evade immune detection (27, 28). The gene discussed is PDCD1; the disease is cancer.